Log In
Print this Print this

Ferinject, Injectafer, ferric carboxymaltose (Z-213)

Also known as: VIT-45

  Manage Alerts
Collapse Summary General Information
Company Galenica Ltd.
DescriptionNon-dextran IV iron replacement
Molecular Target Not applicable
Mechanism of ActionRepletion therapy
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationAnemia
Indication DetailsTreat iron deficiency anemia; Treat iron deficiency anemia in patients with non-dialysis dependent chronic kidney disease (CKD); Treat iron deficiency in patients with chronic heart failure (CHF); Treat iron deficiency in patients with fibromyalgia; Treat iron deficiency-related fatigue in non-anemic premenopausal women
Regulatory Designation
Partner Daiichi Sankyo Co. Ltd.; Fresenius SE & Co. KGaA; Hikma Pharmaceuticals plc; Zeria Pharmaceutical Co. Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments





 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today